Laboratory Investigation

Kidney International (1994) 45, 509–514; doi:10.1038/ki.1994.66

Effect of vitamin D metabolites on calcitriol degradative enzymes in renal failure

Sanjeevkumar R Patel1, Hui Qiong Ke1 and Chen H Hsu1

1Nephrology Division, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA

Correspondence: Chen H Hsu MD, 3914 Taubman Center, Nephrology Division, University Hospital, Ann Arbor, Michigan 48109-0364, USA.

Received 23 June 1993; Revised 1 September 1993; Accepted 2 September 1993.

Top

Abstract

Effect of vitamin D metabolites on calcitriol degradative enzymes in renal failure. We have demonstrated that in renal failure calcitriol degradation is decreased and that administration of vitamin D metabolites increases the degradation. In this study, we measured intestinal 24- and 26-hydroxylase activities and the effects of chronic infusion (7 days) of vitamin D metabolites on these enzymes' activities in rats with experimental renal failure. The enzymatic activity of intestinal 24-hydroxylase, but not 26-hydroxylase, was significantly lower in renal failure rats compared to control sham operated rats. Replacement of calcitriol (3 ng/day) significantly increased 24-hydroxylase activity by 17% in rats with renal failure (P < 0.01), although the activity remained 15% lower than the controls (P < 0.01). Intestinal 26-hydroxylase activity was not lower in renal failure; however, calcitriol treatment increased the activity beyond that of normal controls. In contrast, administration of 25(OH)D3 (600 ng/day) and 24,25(OH)2D3 (1 microg/day) reduced the conversion of calcitriol to 1,24,25(OH)3D3 by more than 50% and to 1,25,26(OH)3D3 by more than 38%, respectively. We conclude that calcitriol increased its own degradation in renal failure by increasing the enzymatic activities of both 24- and 26-hydroxylase. However, the mechanisms of increased calcitriol degradation by 25(OH)D3 and 24,25(OH)2D3 in renal failure remain unknown.

Top

References

  1. Hsu CH, Patel SR, Young EW, Simpson RU: Production and degradation of calcitriol in renal failure rats. Am J Physiol 253:F1015–F1019, 1987 | PubMed | ISI | ChemPort |
  2. Hsu CH, Patel S: 25-hydroxyvitamin D metabolism and its effect on calcitriol metabolism in experimental failure. J Lab Clin Med 116:51–57, 1990
  3. Patel S, Simpson RU, Hsu CH: Effect of vitamin D metabolites on calcitriol metabolism in experimental renal failure. Kidney Int 36:234–239, 1989 | PubMed | ISI | ChemPort |
  4. Hsu CH, Patel SR, Young EW: Mechanism of decreased calcitriol degradation in renal failure. Am J Physiol 262:F192–F198, 1992 | PubMed | ISI | ChemPort |
  5. Hirst M, Feldman D: Regulation of 1,25(OH)2 vitamin D3 receptor content in cultured LLC-PK1 kidney cells limits hormonal responsiveness. Biochem Biophys Res Commun 116:121–127, 1983
  6. Hsu CH, Patel RS, Vanholder R: Mechanism of decreased intestinal calcitriol receptor concentration in renal failure. Am J Physiol 264:F662–F669, 1993 | PubMed | ISI |
  7. Colston K, Feldman D: 1,25-Dihydroxyvitamin D3 receptors and functions in cultured pig kidney cells (LLC PK1). Regulation of 24,25-dihydroxyvitamin D3 production. J Biol Chem 257:2504–2508, 1982
  8. Costa EM, Feldman D: Homologus up-regulation of the 1,25(OH)2 vitamin D3 receptor in rats. Biochem Biophys Res Commun 137:742–747, 1986
  9. Reinhardt TA, Horst RL, Orf JW, Hollis BW: A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: Application to clinical studies. J Clin Endocrinol Metab 58:91–98, 1984 | PubMed | ISI | ChemPort |
  10. Hollis BW: Assay of circulating 1,25-dihydroxyvitamin D involving a novel single-cartridge extraction and purification procedure. Clin Chem 32:2060–2063, 1986 | PubMed | ISI | ChemPort |
  11. Kumar R, Schnoes HK, DeLuca HF: Rat intestinal 25-hydroxyvitamin D3- and lalpha,25-dihydroxyvitamin D3-24-hydroxylase. J Biol Chem 253:3804–3809, 1978 | PubMed | ChemPort |
  12. Dick IM, Retallack R, Prince RL: Rapid nongenomic inhibition of renal 25-hydroxyvitamin D3 1-hydroxylase by 1,25-dihydroxy vitamin D3. Am J Physiol E272–E277, 1990
  13. Horst RL, Hove K, Littledike ET, Reinhardt TA, Uskokovic MR, Partridge JJ: Plasma concentrations of 1,25-dihydroxy vitamin D, 1,24R,25-trihydroxyvitamin D3, and 1,25,26-trihydroxyvitamin D3 after their administration to dairy cows. J Dairy Sci 66:1455–1460, 1983
  14. Colston K, Wilkinson JR, Coombes RC: 1,25-Dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology 119:2214–2220, 1986
  15. Colston KW, Evans IM, Spelsberg TC, MacIntyre I: Feedback regulation of vitamin D metabolism by 1,25-dihydroxycholecalciferol. Biochem J 164:83–89, 1977
  16. Colston K, Feldman D: Nuclear translocation of the 1,25-dihydroxycholecalciferol receptor in mouse kidney. J Biol Chem 255:7510–7513, 1980
  17. Reinhardt TA, Horst RL: Self-induction of 1,25-dihydroxyvitamin D3 metabolism limits receptor occupancy and target tissue responsiveness. J Biol Chem 264:15917–15921, 1989
  18. Beckman MJ, Horst RL, Reinhardt TA, Beitz DC: Up-regulation of the intestinal 1,25-dihydroxy vitamin D receptor during hypervitaminosis D: A comparison between vitamin D2 and vitamin D3. Biochem Biophys Res Commun 169:910–915, 1990 | Article | PubMed | ISI | ChemPort |
  19. Pan LC, Price PA: Ligand-dependent regulation of the 1,25-dihydroxy vitamin D3 receptor in rat osteosarcoma cells. J Biol Chem 262:4670–4675, 1987
  20. Costa EM, Hirst MA, Feldman D: Regulation of 1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells. Endocrinology 117:2203–2210, 1985
  21. Costa EM, Blau HM, Feldman D: Measurement of 1,25-dihydroxyvitamin D3 receptor turnover by dense amino acid labeling: Changes during receptor up-regulation by vitamin D metabolites. Endocrinology 120:1173–1178, 1987 | PubMed | ISI | ChemPort |
  22. Chandler JS, Chandler SK, Pike JW, Haussler MR: 1,25-Dihydroxyvitamin D3 induces 25-hydroxyvitamin D3-24-hydroxylase in a cultured monkey kidney cell line (LLC-MK2) apparently deficient in the high affinity receptor for the hormone. J Biol Chem 259:2214–2222, 1984
  23. Canterbury JM, Gavellas G, Bourgoignie JJ, Reiss E: Metabolic consequences of oral administration of 24,25-dihydroxycholecalciferol to uremic dogs. J Clin Invest 65:571–576, 1980
  24. Chertow BS, Baker GR, Henry HL, Norman AW: Effects of vitamin D metabolites on bovine parathyroid hormone release in vitro. Am J Physiol 238:E384–E388, 1980
  25. Henry H: Regulation of the synthesis of 1,25-dihydroxy vitamin D3 and 24,25-dihydroxyvitamin D3 in kidney cell culture, in Vitamin D. Basic and Clinical Aspects, edited by Kumar R, Boston, Martinus Nijhoff, 1986, pp. 151–174
  26. Olgaard R, Finco P, Schwartz J, Abbelaze M, Teitelbaum S, Avioli A, Klahr S, Slatopolsky E: Effect of 24,25(OH)2D3 on PTH levels and bone histology in dogs with chronic uremia. Kidney Int 26:791–797, 1987
  27. Dusso A, Lopez-Hilker S, Rapp N, Slatopolsky E: Extra-renal production of calcitriol in chronic renal failure. Kidney Int 34:368–375, 1988 | PubMed | ISI | ChemPort |
  28. Halloran HP, Schaefer P, Lifschitz M, Levens M, Goldsmith RS: Plasma vitamin D metabolite concentration in chronic renal failure: Effect of oral administration of 25-hydroxyvitamin D3. J Clin Endocrinol Metab 59:1063–1069, 1984

Extra navigation

.
ADVERTISEMENT